LRRK2 variation and Parkinson's disease in African Americans
Identifieur interne : 000220 ( Istex/Corpus ); précédent : 000219; suivant : 000221LRRK2 variation and Parkinson's disease in African Americans
Auteurs : Owen A. Ross ; Greggory J. Wilhoite ; Justin A. Bacon ; Alexandra Soto-Ortolaza ; Jennifer Kachergus ; Stephanie A. Cobb ; Andreas Puschmann ; Carles Vilari O-Güell ; Matthew J. Farrer ; Neill Graff-Radford ; James F. Meschia ; Zbigniew K. WszolekSource :
- Movement Disorders [ 0885-3185 ] ; 2010-09-15.
English descriptors
- KwdEn :
Abstract
The global impact of LRRK2 mutations is yet to be realized with a lack of studies in specific ethnic groups, including those of Asian and African descent. Herein, we investigated the frequency of common LRRK2 variants by complete exon sequencing in a series of publicly available African American Parkinson's disease patients. Our study identified three novel synonymous exonic variants and 13 known coding variations; however, there did not appear to be any frequent (>5%) pathogenic mutations. Given the ethnic‐specific LRRK2 variation previously identified in PD further studies in under‐represented populations are warranted. © 2010 Movement Disorder Society.
Url:
DOI: 10.1002/mds.23163
Links to Exploration step
ISTEX:050B825DED95CB71E59A3A1EA7D075A512EC35B9Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">LRRK2 variation and Parkinson's disease in African Americans</title>
<author><name sortKey="Ross, Owen A" sort="Ross, Owen A" uniqKey="Ross O" first="Owen A." last="Ross">Owen A. Ross</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Molecular Genetics Laboratory and Core, Department of Neuroscience, Morris K. Udall Parkinson's Disease Research Center of Excellence, Mayo Clinic, 4500 San Pablo Road, Jacksonville, Florida 32224</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Wilhoite, Greggory J" sort="Wilhoite, Greggory J" uniqKey="Wilhoite G" first="Greggory J." last="Wilhoite">Greggory J. Wilhoite</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Bacon, Justin A" sort="Bacon, Justin A" uniqKey="Bacon J" first="Justin A." last="Bacon">Justin A. Bacon</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Soto Rtolaza, Alexandra" sort="Soto Rtolaza, Alexandra" uniqKey="Soto Rtolaza A" first="Alexandra" last="Soto-Ortolaza">Alexandra Soto-Ortolaza</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Kachergus, Jennifer" sort="Kachergus, Jennifer" uniqKey="Kachergus J" first="Jennifer" last="Kachergus">Jennifer Kachergus</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Cobb, Stephanie A" sort="Cobb, Stephanie A" uniqKey="Cobb S" first="Stephanie A." last="Cobb">Stephanie A. Cobb</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Puschmann, Andreas" sort="Puschmann, Andreas" uniqKey="Puschmann A" first="Andreas" last="Puschmann">Andreas Puschmann</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Vilari O Ell, Carles" sort="Vilari O Ell, Carles" uniqKey="Vilari O Ell C" first="Carles" last="Vilari O-Güell">Carles Vilari O-Güell</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Farrer, Matthew J" sort="Farrer, Matthew J" uniqKey="Farrer M" first="Matthew J." last="Farrer">Matthew J. Farrer</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Graff Adford, Neill" sort="Graff Adford, Neill" uniqKey="Graff Adford N" first="Neill" last="Graff-Radford">Neill Graff-Radford</name>
<affiliation><mods:affiliation>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Meschia, James F" sort="Meschia, James F" uniqKey="Meschia J" first="James F." last="Meschia">James F. Meschia</name>
<affiliation><mods:affiliation>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Wszolek, Zbigniew K" sort="Wszolek, Zbigniew K" uniqKey="Wszolek Z" first="Zbigniew K." last="Wszolek">Zbigniew K. Wszolek</name>
<affiliation><mods:affiliation>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:050B825DED95CB71E59A3A1EA7D075A512EC35B9</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.23163</idno>
<idno type="url">https://api.istex.fr/document/050B825DED95CB71E59A3A1EA7D075A512EC35B9/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000220</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000220</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">LRRK2 variation and Parkinson's disease in African Americans</title>
<author><name sortKey="Ross, Owen A" sort="Ross, Owen A" uniqKey="Ross O" first="Owen A." last="Ross">Owen A. Ross</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Molecular Genetics Laboratory and Core, Department of Neuroscience, Morris K. Udall Parkinson's Disease Research Center of Excellence, Mayo Clinic, 4500 San Pablo Road, Jacksonville, Florida 32224</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Wilhoite, Greggory J" sort="Wilhoite, Greggory J" uniqKey="Wilhoite G" first="Greggory J." last="Wilhoite">Greggory J. Wilhoite</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Bacon, Justin A" sort="Bacon, Justin A" uniqKey="Bacon J" first="Justin A." last="Bacon">Justin A. Bacon</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Soto Rtolaza, Alexandra" sort="Soto Rtolaza, Alexandra" uniqKey="Soto Rtolaza A" first="Alexandra" last="Soto-Ortolaza">Alexandra Soto-Ortolaza</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Kachergus, Jennifer" sort="Kachergus, Jennifer" uniqKey="Kachergus J" first="Jennifer" last="Kachergus">Jennifer Kachergus</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Cobb, Stephanie A" sort="Cobb, Stephanie A" uniqKey="Cobb S" first="Stephanie A." last="Cobb">Stephanie A. Cobb</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Puschmann, Andreas" sort="Puschmann, Andreas" uniqKey="Puschmann A" first="Andreas" last="Puschmann">Andreas Puschmann</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Vilari O Ell, Carles" sort="Vilari O Ell, Carles" uniqKey="Vilari O Ell C" first="Carles" last="Vilari O-Güell">Carles Vilari O-Güell</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Farrer, Matthew J" sort="Farrer, Matthew J" uniqKey="Farrer M" first="Matthew J." last="Farrer">Matthew J. Farrer</name>
<affiliation><mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Graff Adford, Neill" sort="Graff Adford, Neill" uniqKey="Graff Adford N" first="Neill" last="Graff-Radford">Neill Graff-Radford</name>
<affiliation><mods:affiliation>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Meschia, James F" sort="Meschia, James F" uniqKey="Meschia J" first="James F." last="Meschia">James F. Meschia</name>
<affiliation><mods:affiliation>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Wszolek, Zbigniew K" sort="Wszolek, Zbigniew K" uniqKey="Wszolek Z" first="Zbigniew K." last="Wszolek">Zbigniew K. Wszolek</name>
<affiliation><mods:affiliation>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-09-15">2010-09-15</date>
<biblScope unit="volume">25</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1973">1973</biblScope>
<biblScope unit="page" to="1976">1976</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">050B825DED95CB71E59A3A1EA7D075A512EC35B9</idno>
<idno type="DOI">10.1002/mds.23163</idno>
<idno type="ArticleID">MDS23163</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>genetics</term>
<term>leucine‐rich repeat kinase 2</term>
<term>parkinsonism</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The global impact of LRRK2 mutations is yet to be realized with a lack of studies in specific ethnic groups, including those of Asian and African descent. Herein, we investigated the frequency of common LRRK2 variants by complete exon sequencing in a series of publicly available African American Parkinson's disease patients. Our study identified three novel synonymous exonic variants and 13 known coding variations; however, there did not appear to be any frequent (>5%) pathogenic mutations. Given the ethnic‐specific LRRK2 variation previously identified in PD further studies in under‐represented populations are warranted. © 2010 Movement Disorder Society.</div>
</front>
</TEI>
<istex><corpusName>wiley</corpusName>
<author><json:item><name>Owen A. Ross PhD</name>
<affiliations><json:string>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</json:string>
<json:string>Molecular Genetics Laboratory and Core, Department of Neuroscience, Morris K. Udall Parkinson's Disease Research Center of Excellence, Mayo Clinic, 4500 San Pablo Road, Jacksonville, Florida 32224</json:string>
</affiliations>
</json:item>
<json:item><name>Greggory J. Wilhoite BS</name>
<affiliations><json:string>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</json:string>
</affiliations>
</json:item>
<json:item><name>Justin A. Bacon BS</name>
<affiliations><json:string>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</json:string>
</affiliations>
</json:item>
<json:item><name>Alexandra Soto‐Ortolaza BS</name>
<affiliations><json:string>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</json:string>
</affiliations>
</json:item>
<json:item><name>Jennifer Kachergus BS</name>
<affiliations><json:string>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</json:string>
</affiliations>
</json:item>
<json:item><name>Stephanie A. Cobb BA</name>
<affiliations><json:string>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</json:string>
</affiliations>
</json:item>
<json:item><name>Andreas Puschmann MD</name>
<affiliations><json:string>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</json:string>
</affiliations>
</json:item>
<json:item><name>Carles Vilariño‐Güell PhD</name>
<affiliations><json:string>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</json:string>
</affiliations>
</json:item>
<json:item><name>Matthew J. Farrer PhD</name>
<affiliations><json:string>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</json:string>
</affiliations>
</json:item>
<json:item><name>Neill Graff‐Radford MD</name>
<affiliations><json:string>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</json:string>
</affiliations>
</json:item>
<json:item><name>James F. Meschia MD</name>
<affiliations><json:string>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</json:string>
</affiliations>
</json:item>
<json:item><name>Zbigniew K. Wszolek MD</name>
<affiliations><json:string>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>parkinsonism</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>leucine‐rich repeat kinase 2</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>genetics</value>
</json:item>
</subject>
<articleId><json:string>MDS23163</json:string>
</articleId>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>article</json:string>
</originalGenre>
<abstract>The global impact of LRRK2 mutations is yet to be realized with a lack of studies in specific ethnic groups, including those of Asian and African descent. Herein, we investigated the frequency of common LRRK2 variants by complete exon sequencing in a series of publicly available African American Parkinson's disease patients. Our study identified three novel synonymous exonic variants and 13 known coding variations; however, there did not appear to be any frequent (>5%) pathogenic mutations. Given the ethnic‐specific LRRK2 variation previously identified in PD further studies in under‐represented populations are warranted. © 2010 Movement Disorder Society.</abstract>
<qualityIndicators><score>6.164</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>612 x 810 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractCharCount>663</abstractCharCount>
<pdfWordCount>10818</pdfWordCount>
<pdfCharCount>71882</pdfCharCount>
<pdfPageCount>20</pdfPageCount>
<abstractWordCount>97</abstractWordCount>
</qualityIndicators>
<title>LRRK2 variation and Parkinson's disease in African Americans</title>
<genre><json:string>article</json:string>
</genre>
<host><volume>25</volume>
<publisherId><json:string>MDS</json:string>
</publisherId>
<pages><total>4</total>
<last>1976</last>
<first>1973</first>
</pages>
<issn><json:string>0885-3185</json:string>
</issn>
<issue>12</issue>
<subject><json:item><value>Brief Report</value>
</json:item>
</subject>
<genre><json:string>journal</json:string>
</genre>
<language><json:string>unknown</json:string>
</language>
<eissn><json:string>1531-8257</json:string>
</eissn>
<title>Movement Disorders</title>
<doi><json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<categories><wos><json:string>science</json:string>
<json:string>clinical neurology</json:string>
</wos>
<scienceMetrix><json:string>health sciences</json:string>
<json:string>clinical medicine</json:string>
<json:string>neurology & neurosurgery</json:string>
</scienceMetrix>
</categories>
<publicationDate>2010</publicationDate>
<copyrightDate>2010</copyrightDate>
<doi><json:string>10.1002/mds.23163</json:string>
</doi>
<id>050B825DED95CB71E59A3A1EA7D075A512EC35B9</id>
<score>0.12237979</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/050B825DED95CB71E59A3A1EA7D075A512EC35B9/fulltext/pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/050B825DED95CB71E59A3A1EA7D075A512EC35B9/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/050B825DED95CB71E59A3A1EA7D075A512EC35B9/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">LRRK2 variation and Parkinson's disease in African Americans</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability><p>Published 2010 Wiley‐Liss, Inc.</p>
</availability>
<date>2010</date>
</publicationStmt>
<notesStmt><note type="content">*Potential conflict of interest: None.</note>
<note>The Michael J. Fox foundation</note>
<note>NIH - No. P01 AG017216; No. R01 NS057567; No. R01 AG015866; No. CIHR 121849; No. PARF C06‐01;</note>
</notesStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">LRRK2 variation and Parkinson's disease in African Americans</title>
<author xml:id="author-1"><persName><forename type="first">Owen A.</forename>
<surname>Ross</surname>
</persName>
<roleName type="degree">PhD</roleName>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
<affiliation>Molecular Genetics Laboratory and Core, Department of Neuroscience, Morris K. Udall Parkinson's Disease Research Center of Excellence, Mayo Clinic, 4500 San Pablo Road, Jacksonville, Florida 32224</affiliation>
</author>
<author xml:id="author-2"><persName><forename type="first">Greggory J.</forename>
<surname>Wilhoite</surname>
</persName>
<roleName type="degree">BS</roleName>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
</author>
<author xml:id="author-3"><persName><forename type="first">Justin A.</forename>
<surname>Bacon</surname>
</persName>
<roleName type="degree">BS</roleName>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
</author>
<author xml:id="author-4"><persName><forename type="first">Alexandra</forename>
<surname>Soto‐Ortolaza</surname>
</persName>
<roleName type="degree">BS</roleName>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
</author>
<author xml:id="author-5"><persName><forename type="first">Jennifer</forename>
<surname>Kachergus</surname>
</persName>
<roleName type="degree">BS</roleName>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
</author>
<author xml:id="author-6"><persName><forename type="first">Stephanie A.</forename>
<surname>Cobb</surname>
</persName>
<roleName type="degree">BA</roleName>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
</author>
<author xml:id="author-7"><persName><forename type="first">Andreas</forename>
<surname>Puschmann</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
</author>
<author xml:id="author-8"><persName><forename type="first">Carles</forename>
<surname>Vilariño‐Güell</surname>
</persName>
<roleName type="degree">PhD</roleName>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
</author>
<author xml:id="author-9"><persName><forename type="first">Matthew J.</forename>
<surname>Farrer</surname>
</persName>
<roleName type="degree">PhD</roleName>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
</author>
<author xml:id="author-10"><persName><forename type="first">Neill</forename>
<surname>Graff‐Radford</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
</author>
<author xml:id="author-11"><persName><forename type="first">James F.</forename>
<surname>Meschia</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
</author>
<author xml:id="author-12"><persName><forename type="first">Zbigniew K.</forename>
<surname>Wszolek</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
</author>
</analytic>
<monogr><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-09-15"></date>
<biblScope unit="volume">25</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1973">1973</biblScope>
<biblScope unit="page" to="1976">1976</biblScope>
</imprint>
</monogr>
<idno type="istex">050B825DED95CB71E59A3A1EA7D075A512EC35B9</idno>
<idno type="DOI">10.1002/mds.23163</idno>
<idno type="ArticleID">MDS23163</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>2010</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
<abstract xml:lang="en"><p>The global impact of LRRK2 mutations is yet to be realized with a lack of studies in specific ethnic groups, including those of Asian and African descent. Herein, we investigated the frequency of common LRRK2 variants by complete exon sequencing in a series of publicly available African American Parkinson's disease patients. Our study identified three novel synonymous exonic variants and 13 known coding variations; however, there did not appear to be any frequent (>5%) pathogenic mutations. Given the ethnic‐specific LRRK2 variation previously identified in PD further studies in under‐represented populations are warranted. © 2010 Movement Disorder Society.</p>
</abstract>
<textClass xml:lang="en"><keywords scheme="keyword"><list><head>keywords</head>
<item><term>parkinsonism</term>
</item>
<item><term>leucine‐rich repeat kinase 2</term>
</item>
<item><term>genetics</term>
</item>
</list>
</keywords>
</textClass>
<textClass><keywords scheme="Journal Subject"><list><head>article-category</head>
<item><term>Brief Report</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc><change when="2009-10-13">Received</change>
<change when="2010-03-17">Registration</change>
<change when="2010-09-15">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/050B825DED95CB71E59A3A1EA7D075A512EC35B9/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup><id type="product" value="MDS"></id>
</idGroup>
<titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="120"><doi origin="wiley" registered="yes">10.1002/mds.v25:12</doi>
<numberingGroup><numbering type="journalVolume" number="25">25</numbering>
<numbering type="journalIssue">12</numbering>
</numberingGroup>
<coverDate startDate="2010-09-15">15 September 2010</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="290" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.23163</doi>
<idGroup><id type="unit" value="MDS23163"></id>
</idGroup>
<countGroup><count type="pageTotal" number="4"></count>
</countGroup>
<titleGroup><title type="articleCategory">Brief Report</title>
<title type="tocHeading1">Brief Reports</title>
</titleGroup>
<copyright ownership="thirdParty">Published 2010 Wiley‐Liss, Inc.</copyright>
<eventGroup><event type="manuscriptReceived" date="2009-10-13"></event>
<event type="manuscriptRevised" date="2010-02-19"></event>
<event type="manuscriptAccepted" date="2010-03-17"></event>
<event type="firstOnline" date="2010-07-28"></event>
<event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2010-07-28"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4.7 mode:FullText source:FullText result:FullText" date="2011-02-24"></event>
<event type="publishedOnlineFinalForm" date="2010-09-08"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst">1973</numbering>
<numbering type="pageLast">1976</numbering>
</numberingGroup>
<correspondenceTo>Molecular Genetics Laboratory and Core, Department of Neuroscience, Morris K. Udall Parkinson's Disease Research Center of Excellence, Mayo Clinic, 4500 San Pablo Road, Jacksonville, Florida 32224</correspondenceTo>
<linkGroup><link type="toTypesetVersion" href="file:MDS.MDS23163.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><countGroup><count type="figureTotal" number="1"></count>
<count type="tableTotal" number="1"></count>
<count type="referenceTotal" number="14"></count>
<count type="wordTotal" number="2741"></count>
</countGroup>
<titleGroup><title type="main" xml:lang="en"><i>LRRK2</i>
variation and Parkinson's disease in African Americans<link href="#fn2"></link>
</title>
<title type="short" xml:lang="en">LRRK2‐<fi>Parkinsonism in African Americans</fi>
</title>
</titleGroup>
<creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Owen A.</givenNames>
<familyName>Ross</familyName>
<degrees>PhD</degrees>
</personName>
<contactDetails><email>ross.owen@mayo.edu</email>
</contactDetails>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Greggory J.</givenNames>
<familyName>Wilhoite</familyName>
<degrees>BS</degrees>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Justin A.</givenNames>
<familyName>Bacon</familyName>
<degrees>BS</degrees>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Alexandra</givenNames>
<familyName>Soto‐Ortolaza</familyName>
<degrees>BS</degrees>
</personName>
</creator>
<creator xml:id="au5" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Jennifer</givenNames>
<familyName>Kachergus</familyName>
<degrees>BS</degrees>
</personName>
</creator>
<creator xml:id="au6" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Stephanie A.</givenNames>
<familyName>Cobb</familyName>
<degrees>BA</degrees>
</personName>
</creator>
<creator xml:id="au7" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Andreas</givenNames>
<familyName>Puschmann</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au8" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Carles</givenNames>
<familyName>Vilariño‐Güell</familyName>
<degrees>PhD</degrees>
</personName>
</creator>
<creator xml:id="au9" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Matthew J.</givenNames>
<familyName>Farrer</familyName>
<degrees>PhD</degrees>
</personName>
</creator>
<creator xml:id="au10" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Neill</givenNames>
<familyName>Graff‐Radford</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au11" creatorRole="author" affiliationRef="#af2"><personName><givenNames>James F.</givenNames>
<familyName>Meschia</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au12" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Zbigniew K.</givenNames>
<familyName>Wszolek</familyName>
<degrees>MD</degrees>
</personName>
</creator>
</creators>
<affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">parkinsonism</keyword>
<keyword xml:id="kwd2">leucine‐rich repeat kinase 2</keyword>
<keyword xml:id="kwd3">genetics</keyword>
</keywordGroup>
<fundingInfo><fundingAgency>The Michael J. Fox foundation</fundingAgency>
</fundingInfo>
<fundingInfo><fundingAgency>NIH</fundingAgency>
<fundingNumber>P01 AG017216</fundingNumber>
<fundingNumber>R01 NS057567</fundingNumber>
<fundingNumber>R01 AG015866</fundingNumber>
<fundingNumber>CIHR 121849</fundingNumber>
<fundingNumber>PARF C06‐01</fundingNumber>
</fundingInfo>
<abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title>
<p>The global impact of <i>LRRK2</i>
mutations is yet to be realized with a lack of studies in specific ethnic groups, including those of Asian and African descent. Herein, we investigated the frequency of common <i>LRRK2</i>
variants by complete exon sequencing in a series of publicly available African American Parkinson's disease patients. Our study identified three novel synonymous exonic variants and 13 known coding variations; however, there did not appear to be any frequent (>5%) pathogenic mutations. Given the ethnic‐specific <i>LRRK2</i>
variation previously identified in PD further studies in under‐represented populations are warranted. © 2010 Movement Disorder Society.</p>
</abstract>
</abstractGroup>
</contentMeta>
<noteGroup><note xml:id="fn2"><p>Potential conflict of interest: None.</p>
</note>
</noteGroup>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>LRRK2 variation and Parkinson's disease in African Americans</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en"><title>LRRK2‐Parkinsonism in African Americans</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>LRRK2 variation and Parkinson's disease in African Americans</title>
</titleInfo>
<name type="personal"><namePart type="given">Owen A.</namePart>
<namePart type="family">Ross</namePart>
<namePart type="termsOfAddress">PhD</namePart>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
<affiliation>Molecular Genetics Laboratory and Core, Department of Neuroscience, Morris K. Udall Parkinson's Disease Research Center of Excellence, Mayo Clinic, 4500 San Pablo Road, Jacksonville, Florida 32224</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Greggory J.</namePart>
<namePart type="family">Wilhoite</namePart>
<namePart type="termsOfAddress">BS</namePart>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Justin A.</namePart>
<namePart type="family">Bacon</namePart>
<namePart type="termsOfAddress">BS</namePart>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Alexandra</namePart>
<namePart type="family">Soto‐Ortolaza</namePart>
<namePart type="termsOfAddress">BS</namePart>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Jennifer</namePart>
<namePart type="family">Kachergus</namePart>
<namePart type="termsOfAddress">BS</namePart>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Stephanie A.</namePart>
<namePart type="family">Cobb</namePart>
<namePart type="termsOfAddress">BA</namePart>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Andreas</namePart>
<namePart type="family">Puschmann</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Carles</namePart>
<namePart type="family">Vilariño‐Güell</namePart>
<namePart type="termsOfAddress">PhD</namePart>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Matthew J.</namePart>
<namePart type="family">Farrer</namePart>
<namePart type="termsOfAddress">PhD</namePart>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Neill</namePart>
<namePart type="family">Graff‐Radford</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">James F.</namePart>
<namePart type="family">Meschia</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Zbigniew K.</namePart>
<namePart type="family">Wszolek</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article"></genre>
<originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place><placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2010-09-15</dateIssued>
<dateCaptured encoding="w3cdtf">2009-10-13</dateCaptured>
<dateValid encoding="w3cdtf">2010-03-17</dateValid>
<copyrightDate encoding="w3cdtf">2010</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
<extent unit="figures">1</extent>
<extent unit="tables">1</extent>
<extent unit="references">14</extent>
<extent unit="words">2741</extent>
</physicalDescription>
<abstract lang="en">The global impact of LRRK2 mutations is yet to be realized with a lack of studies in specific ethnic groups, including those of Asian and African descent. Herein, we investigated the frequency of common LRRK2 variants by complete exon sequencing in a series of publicly available African American Parkinson's disease patients. Our study identified three novel synonymous exonic variants and 13 known coding variations; however, there did not appear to be any frequent (>5%) pathogenic mutations. Given the ethnic‐specific LRRK2 variation previously identified in PD further studies in under‐represented populations are warranted. © 2010 Movement Disorder Society.</abstract>
<note type="content">*Potential conflict of interest: None.</note>
<note type="funding">The Michael J. Fox foundation</note>
<note type="funding">NIH - No. P01 AG017216; No. R01 NS057567; No. R01 AG015866; No. CIHR 121849; No. PARF C06‐01; </note>
<subject lang="en"><genre>keywords</genre>
<topic>parkinsonism</topic>
<topic>leucine‐rich repeat kinase 2</topic>
<topic>genetics</topic>
</subject>
<relatedItem type="host"><titleInfo><title>Movement Disorders</title>
</titleInfo>
<titleInfo type="abbreviated"><title>Mov. Disord.</title>
</titleInfo>
<genre type="journal">journal</genre>
<subject><genre>article-category</genre>
<topic>Brief Report</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part><date>2010</date>
<detail type="volume"><caption>vol.</caption>
<number>25</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>12</number>
</detail>
<extent unit="pages"><start>1973</start>
<end>1976</end>
<total>4</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">050B825DED95CB71E59A3A1EA7D075A512EC35B9</identifier>
<identifier type="DOI">10.1002/mds.23163</identifier>
<identifier type="ArticleID">MDS23163</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Published 2010 Wiley‐Liss, Inc.</accessCondition>
<recordInfo><recordContentSource>WILEY</recordContentSource>
<recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/DanceTherParkinsonV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000220 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000220 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Psychologie |area= DanceTherParkinsonV1 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:050B825DED95CB71E59A3A1EA7D075A512EC35B9 |texte= LRRK2 variation and Parkinson's disease in African Americans }}
This area was generated with Dilib version V0.6.35. |